Status:
TERMINATED
Impact of HPV Vaccination to Catch up in the Emergence of Lesions of the Cervix
Lead Sponsor:
University Hospital, Brest
Conditions:
HPV Vaccination
Pap Smear
Eligibility:
FEMALE
25-33 years
Brief Summary
In France, the vaccination coverage observed for HPV vaccination is low for a full-scale regimen, and has been falling since 2010. A high rate of HPV vaccination coverage has a significant epidemiolog...
Detailed Description
In France, the observed vaccination coverage is very low for a complete regimen and has been declining since 2010. This low coverage makes it impossible to benefit from the efficiency observed in the ...
Eligibility Criteria
Inclusion
- women
- aged 25 to 33 in 2017
- with a smear analyzed at the Brest University Hospital
Exclusion
- men
- age over 33 years or less than 25 years
- patient refusing to participate
Key Trial Info
Start Date :
December 4 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 19 2021
Estimated Enrollment :
191 Patients enrolled
Trial Details
Trial ID
NCT03328013
Start Date
December 4 2017
End Date
October 19 2021
Last Update
October 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Brest
Brest, France, 29609